Finance

Lists
Why is UPB down 2,80%?
Dive Deeper
UPB:NASDAQ
Upstream Bio Inc
2,78 $
-2,80%
(-0,080) 1D
13 նոյ, 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for UPB...
Open
2,86 $
High
2,98 $
Low
2,73 $
Mkt. cap
152,38 մլն
Avg. vol.
1,32 մլն
Volume
891,33 հզր
52-wk high
33,68 $
52-wk low
2,68 $
EPS
-2,89 $
Shares outstanding
54,81 մլն
No. of employees
75
Open
2,86 $
High
2,98 $
Low
2,73 $
Mkt. cap
152,38 մլն
Avg. vol.
1,32 մլն
Volume
891,33 հզր
52-wk high
33,68 $
52-wk low
2,68 $
EPS
-2,89 $
Shares outstanding
54,81 մլն
No. of employees
75
News stories
From web sources and news partners
About Upstream Bio Inc
CEO-
Employees75
Founded2021
HeadquartersՈւոլթեմ, Մասսաչուսեթս, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Analyst ratings
Based on 3 analysts giving stock ratings to UPB in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for UPB in the last 3 months.
Highest
Current 2,78 $
19,00 $ (+583,45%)
Average
18,50 $ (+565,47%)
Lowest
18,00 $ (+547,48%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
18,00 $
+547,5%
11/11/2026
Matt Phipps
William Blair
Buy
Maintained
-
-
09/08/2026
Kate Dellorusso
LifeSci Capital
Buy
Maintained
19,00 $
+583,5%
09/01/2026
Tessa Romero
J.P. Morgan
Hold
Maintained
9,00 $
+223,7%
08/14/2026
Danielle Brill
Truist Financial
Buy
Maintained
25,00 $
+799,3%
08/12/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
75,00 $
+2 597,8%
06/25/2026
Joseph Catanzaro
Mizuho Securities
Buy
Maintained
50,00 $
+1 698,6%
05/14/2026
Yaron Werber
TD Cowen
Buy
Maintained
-
-
05/13/2026
Cory Kasimov
Evercore ISI
Hold
Downgraded
15,00 $
+439,6%
03/27/2026
Last report
04 նոյ, 2026 թ.
Fiscal period
Q3 2026
-0,75 $ / -0,73 $
-2,93%miss
Revenue / Est. (USD)
395,00 հզր / 480,29 հզր
-17,76%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
668,00 հզր
1,03 մլն
773,00 հզր
395,00 հզր
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
40,17 մլն
36,56 մլն
36,09 մլն
36,61 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,67 մլն
8,08 մլն
7,05 մլն
7,16 մլն
Operating expense
46,84 մլն
44,65 մլն
43,14 մլն
43,77 մլն
Total operating expenses
46,84 մլն
44,65 մլն
43,14 մլն
43,77 մլն
Operating income
-46,17 մլն
-43,62 մլն
-42,37 մլն
-43,38 մլն
Other non operating income
54,00 հզր
-30,00 հզր
7,00 հզր
-43,00 հզր
EBT including unusual items
-42,46 մլն
-40,59 մլն
-39,70 մլն
-41,19 մլն
EBT excluding unusual items
-42,46 մլն
-40,59 մլն
-39,70 մլն
-41,19 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-42,46 մլն
-40,59 մլն
-39,70 մլն
-41,19 մլն
Net profit margin
-6 356,14%
-3 925,63%
-5 136,09%
-10 428,35%
Earnings per share
-0,78
-0,75
-0,73
-0,75
Interest and investment income
3,65 մլն
3,05 մլն
2,66 մլն
2,23 մլն
Interest expense
-
-
-
-
Net interest expenses
3,65 մլն
3,05 մլն
2,66 մլն
2,23 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-46,11 մլն
-43,57 մլն
-42,32 մլն
-43,33 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps